Ligand validation:6GFK

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 6GFK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GFK_SAH_A_301	61%	61%	0.168	0.957	0.59	0.87	-	1	0	0	100%	1
6GFK_SAH_B_301	52%	56%	0.172	0.931	0.59	1.07	-	2	0	0	100%	1
6GFK_SAH_C_301	36%	57%	0.199	0.893	0.56	1.05	-	2	0	0	100%	1
6B92_SAH_A_305	72%	28%	0.134	0.958	1.62	1.41	6	6	2	0	100%	1
2H00_SAH_B_301	66%	27%	0.131	0.937	1.35	1.73	2	4	0	0	100%	1
6GFN_SAH_A_300	35%	34%	0.233	0.921	1.05	1.63	2	4	0	0	100%	1
5PA0_SAH_A_301	100%	34%	0.043	0.994	1.11	1.59	2	3	1	0	100%	1
5P9P_SAH_A_304	100%	47%	0.043	0.992	0.96	1.12	-	2	1	0	100%	1
7UX7_SAH_A_401	100%	60%	0.046	0.994	0.66	0.84	-	1	0	0	100%	1
5P9O_SAH_A_302	100%	32%	0.044	0.991	1.38	1.42	3	4	0	0	100%	1
4QPN_SAH_A_301	100%	49%	0.046	0.993	0.91	1.05	2	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.